Maharashtra’s Food and Drugs Administration (FDA) has ordered filing of an FIR against e-commerce major Snapdeal.com’s CEO Kunal Bahl and directors on Friday. The FIR has been lodged in a case related to alleged sale of medicines, including prescription drugs on its website.

FDA Commissioner Harshadeep Kamble confirmed the news in Mumbai. When contacted, the company spokesperson did not offer any immediate comment.

Last month, FDA had raided the company’s premises in Mumbai in this regard. At that time, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.

FDA had earlier issued a notice to the company and it was asked to furnish details of the drugs offered for sale, distribution and exhibited for sale on its website Snapdeal.com.

The raid followed FDA receiving information that various medicines, including prescription drugs, were being sold online through Snapdeal.com.

As per the law, only a licensed retailer can sell drugs, and that too on the basis of prescription of a doctor, Kamble said, adding such type of online sale of drugs is not allowed as self medication can be harmful.

(With inputs from PTI)

--------------------------------------------------------------------------------------------RELATED STORIES
1. Maharashtra FDA Raids Snapdeal Office For Selling Medicines
2. This is Big! Snapdeal Adds Muscle, Acquires FreeCharge